Psychedelic drug MDMA may help people manage PTSD symptoms. But it should only be used in certain contexts, according to two ...

According to a First Responder Mental Health Needs Assessment conducted in 2025 by the Benjamin Center for Public Policy Initiatives at SUNY, New Paltz, first responder mental health remained at ...

BERKELEY, CA - March 17, 2026 - PRESSADVANTAGE - Malachi Gillihan, Trauma Specialist, is a private practice based in ...

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.

Glen Klein said he endured years of nightmares, heavy drinking and bouts of rage before he sought help for post-traumatic stress disorder. The old, yet lingering stigmas surrounding mental health ...

A drug prescribed to veterans suffering from post-traumatic stress disorder nightmares has been recalled for high traces of a chemical that could be cancerous. Food and Drug Administration recalled ...

This report calls on those who oversee the funding and implementation of PTSD research to reject animal-based research on PTSD and other mental illnesses In the United States, over 6% of adults are ...

People with traumatic brain injury often experience post-traumatic stress disorder (PTSD), and the psychedelic drug ibogaine seems to alleviate these symptoms – which it may do by slowing down ...

A University of Alabama at Birmingham expert unpacks the complexities of PTSD, its impact on the brain and sleep, and how individuals can navigate emotional and cognitive challenges through treatment.

A promising new drug could help people living with post-traumatic stress disorder (PTSD) finally let go of trauma. This is the discovery of scientists at the Institute of Basic Science (IBS) and Ewha ...

Researchers discovered that PTSD may be driven by excess GABA from astrocytes, not neurons. This chemical imbalance disrupts the brain’s ability to forget fear. A new drug, KDS2010, reverses this ...